The global market for robotic surgery systems approached $2.63 billion in 2019 and is projected to increase 18.2% annually through 2024 to $6.07 billion. These figures include the capital equipment, service and training but exclude proprietary instruments, implants and accessories which also represent a multi-billion dollar market. Growth will be strong in all segments—even the established laparoscopic segment—based on increasing global adoption of these technologies to enable more predictable surgical outcomes, especially for challenging cases. Laparoscopic systems will remain the dominant type based on their application to numerous surgical procedures. However, as emerging segments, bronchoscopic and cardiovascular robotic systems will see the fastest gains.
Accuray
Activ Surgical
AiM Robotics, Inc.
Aktormed GmbH
A-Traction, Inc.
Auris Health, Inc.
Avatera Medical GmbH
AVRA Medical Robotics, Inc.
CMR Surgical, Ltd.
Corindus Vascular Robotics
Curexo, Inc.
Globus Medical, Inc.
IMRIS, Inc.
Intuitive Surgical
MacDonald, Dettwiler and Associates, Ltd. (MDA)
Medical Surgery Technologies (MST)
Medicaroid
MedRobotics
Medtronic
Meere Company
Memic
Microbot Medical, Inc.
OMNILife Sciences, Inc.
Renishaw Plc.
Riverfield, Inc.
Robocath, Inc.
Smith and Nephew, Plc.
Stereotaxis, Inc.
Stryker, Inc.
Synaptive, Inc.
Think Surgical
Titan Medical, Inc.
TransEnterix, Inc.
Verb Surgical
Virtual Incision Corporation
XACT Robotics, Ltd.
XSurgical, Inc.
Zimmer Biomet Holdings, Inc.
© 2024 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy
